Researchers Dashboard

Overview

This dashboard provides comprehensive statistics and analytics for neurodegenerative disease researchers in NeuroWiki. The researcher database captures key opinion leaders, principal investigators, and translational researchers driving the field forward.

Summary Statistics

| Metric | Value |
|--------|-------|
| Total Researcher Pages | [@neurowiki2026]158 |
| [Alzheimer's](/diseases/alzheimers-disease) Researchers | 89 |
| [Parkinson's](/diseases/parkinsons-disease) Researchers | 67 |
| ALS Researchers | 52 |
| FTD Researchers | 34 |
| Industry Researchers | 41 |
| Academic Researchers | 117 |

Research Focus Areas

Alzheimer's Disease (AD)

89 researchers focused on amyloid, [tau](/proteins/tau), biomarkers, and clinical trials.

Key Leaders:

• [Kaj Blennow](/researchers/kaj-blennow) — Biomarkers
• [John Trojanowski](/researchers/john-trojanowski) — Tau, biomarkers
• [Reisa Sperling](/researchers/reisa-sperling) — Clinical trials
• [David Holtzman](/researchers/david-holtzman) — Amyloid, tau
• [Rudolph Tanzi](/researchers/rudolph-tanzi) — Genetics, amyloid

Parkinson's Disease (PD)

67 researchers focused on [alpha-synuclein](/proteins/alpha-synuclein), [LRRK2](/entities/lrrk2), genetics.

Key Leaders:

• [Virginia Lee](/researchers/virginia-lee) — Alpha-synuclein
• [Kenneth Kosik](/researchers/kenneth-kosik) — Genetics
• Birgitt Schuehle — LRRK2

Amyotrophic Lateral SALS (ALS)

52 researchers focused on SOD1, [C9orf72](/entities/c9orf72), clinical trials.

Frontotemporal Dementia (FTD)

Overview

This dashboard provides comprehensive statistics and analytics for neurodegenerative disease researchers in NeuroWiki. The researcher database captures key opinion leaders, principal investigators, and translational researchers driving the field forward.

Summary Statistics

| Metric | Value |
|--------|-------|
| Total Researcher Pages | [@neurowiki2026]158 |
| [Alzheimer's](/diseases/alzheimers-disease) Researchers | 89 |
| [Parkinson's](/diseases/parkinsons-disease) Researchers | 67 |
| ALS Researchers | 52 |
| FTD Researchers | 34 |
| Industry Researchers | 41 |
| Academic Researchers | 117 |

Research Focus Areas

Alzheimer's Disease (AD)

89 researchers focused on amyloid, [tau](/proteins/tau), biomarkers, and clinical trials.

Key Leaders:

• [Kaj Blennow](/researchers/kaj-blennow) — Biomarkers
• [John Trojanowski](/researchers/john-trojanowski) — Tau, biomarkers
• [Reisa Sperling](/researchers/reisa-sperling) — Clinical trials
• [David Holtzman](/researchers/david-holtzman) — Amyloid, tau
• [Rudolph Tanzi](/researchers/rudolph-tanzi) — Genetics, amyloid

Parkinson's Disease (PD)

67 researchers focused on [alpha-synuclein](/proteins/alpha-synuclein), [LRRK2](/entities/lrrk2), genetics.

Key Leaders:

• [Virginia Lee](/researchers/virginia-lee) — Alpha-synuclein
• [Kenneth Kosik](/researchers/kenneth-kosik) — Genetics
• Birgitt Schuehle — LRRK2

Amyotrophic Lateral SALS (ALS)

52 researchers focused on SOD1, [C9orf72](/entities/c9orf72), clinical trials.

Frontotemporal Dementia (FTD)

34 researchers focused on tau, [TDP-43](/mechanisms/tdp-43-proteinopathy), progranulin.

Institution Distribution

| Institution | Researchers |
|-------------|------------|
| Harvard/Mass General | 18 |
| UCSF | 14 |
| University of Pennsylvania | 12 |
| Mayo Clinic | 10 |
| Stanford | 9 |
| Mount Sinai | 8 |
| UCL | 7 |
| NIH | 6 |
| Cambridge | 5 |
| Other | 69 |

Research Themes

Biomarkers & Diagnostics

Researchers developing CSF, blood, and imaging biomarkers for early detection and treatment monitoring.

Genetics & Genomics

Researchers identifying disease genes, risk factors, and mechanistic insights through GWAS and sequencing.

Clinical Trials

Researchers designing and leading Phase 1-3 trials for novel therapeutics.

Basic Mechanisms

Researchers elucidating protein aggregation, neuroinflammation, and cellular dysfunction.

Top-Cited Researchers

Based on publication impact and field contribution:

| Researcher | Institution | Focus | Key Contributions |
|------------|-------------|-------|-------------------|
| [Kaj Blennow](/researchers/kaj-blennow) | U. Gothenburg | Biomarkers | p-tau, [NFL](/biomarkers/neurofilament-light-chain-nfl), CSF |
| [John Trojanowski](/researchers/john-trojanowski) | UPenn | Tau, FTD | TDP-43, biomarkers |
| [Virginia Lee](/researchers/virginia-lee) | UCSF | Alpha-synuclein | PD, MSA models |
| [David Holtzman](/researchers/david-holtzman) | Washington U | Amyloid | [APP](/entities/app-protein), [APOE](/proteins/apoe) |
| [Henrik Zetterberg](/researchers/henrik-zetterberg) | U. Gothenburg | Biomarkers | p-tau, NFL |

Industry Researchers

41 researchers from pharmaceutical and biotech companies driving translational research.

Key Companies

• [Biogen](/companies/biogen) — 8 researchers
• [Eli Lilly](/companies/eli-lilly) — 5 researchers
• [Roche](/companies/roche) — 4 researchers
• [AbbVie](/companies/abbvie) — 4 researchers
• [Denali](/companies/denali) — 3 researchers

Career Stage Distribution

| Stage | Count |
|-------|-------|
| Senior (Professor/Director) | 78 |
| Mid-career (Associate Professor) | 45 |
| Early-career (Assistant Professor) | 28 |
| Trainee (Postdoc) | 7 |

Gender Distribution

| Gender | Percentage |
|--------|------------|
| Male | 68% |
| Female | 29% |
| Unknown | 3% |

Related Pages

• [Researchers Index](/researchers) — Full researcher directory
• [Researchers Overview](/researchers/overview) — Methodology
• [Researchers Rankings](/researchers/rankings) — Impact rankings
• [Institutions](/institutions) — Research institutions

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References